EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Huntington’s disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion

Eunhye Lee iD, Wonju Kim iD, David H Beier, Yejin Lee, Marina Kovalenko, Faaiza Saif, Esaria Oliver iD, Bhairavi Srinageshwar, Ryan Murtha, Marissa A Andrew, Andrew Jiang, Tammy Gillis und 11 weitere

Proceedings of the National Academy of Sciences · 10.03.2026 · 123 (10)

DOI: 10.1073/pnas.2518854123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 02.03.2026. Verfasst von Eunhye Lee und 22 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114. Hauptthemen laut MEDLINE: DNA Ligase ATP, Huntington Disease, Trinucleotide Repeat Expansion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington’s disease (HD) is a fatal neurodegenerative disorder caused by inheriting an expanded CAG repeat tract in the huntingtin gene ( HTT ) that further expands in somatic cells over an individual’s lifetime. Genome-wide association studies have provided critical insight into factors that modify the course of disease. These include DNA repair genes that alter the rate of somatic expansion and other genes that do not appear to directly influence this process. One modifier gene is DNA ligase 1 ( LIG1 ), in which a variant specifying a lysine to asparagine substitution (K845N) is associated with a profound (7 to 8 y) delay in the onset of motor signs. Here, we have taken a multifaceted approach to gain insight into the protective nature of this variant in HD. We demonstrate using in vitro ligase assays and enzyme kinetics that K845N enhances discrimination toward mismatched substrates and increases repair fidelity. Consistent with increased ligation fidelity, K845N confers protection against oxidative stress in cell-based assays. Finally, we demonstrate that the mouse LIG1 K843N orthologue suppresses somatic CAG expansion in HD knock-in mice. Overall, our data provide evidence that altered LIG1 function due to the K845N substitution may contribute to HD clinical delay by slowing somatic expansion in the brain and protecting the genome globally against damage. Significantly, our results provide a mechanistic foundation for considering DNA ligase fidelity as a therapeutic target in HD and potentially in other trinucleotide repeat disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Ligase ATPHuntington DiseaseTrinucleotide Repeat ExpansionAnimalsHumansMiceHuntingtin ProteinDNA RepairOxidative Stress

Stichwörter der Autor:innen

DNA damageDNA ligase 1Huntington’s diseaserepair fidelitysomatic repeat expansion

Substanzen

DNA Ligase ATPHuntingtin ProteinLIG1 protein, humanLig1 protein, mouse

Autor:innen und Institutionen

  • Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114.
  • Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
  • Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109.
  • CHDI Management Inc., Princeton, NJ 08540.
  • Medical and Population Genetics Program, The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
  • Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.

ORCID-Profile: Eunhye Lee, Wonju Kim, Esaria Oliver, Ricardo Mouro Pinto, Patrick J O'Brien, Ihn Sik Seong

Förderung

  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
  • NINDS NIH HHS
  • CHDI Foundation (CHDI)
  • NSF | NSF Graduate Research Fellowship Program (GRFP)

Zitieren

APA

Lee, E., Kim, W., Beier, D. H., Lee, Y., Kovalenko, M., Saif, F., Oliver, E., Srinageshwar, B., Murtha, R., Andrew, M. A., Jiang, A., Gillis, T., Demelo, B., Ruliera, J., Lucente, D., Kwak, S., Lee, R., Pinto, R. M., MacDonald, M. E., …, & Seong, I. S. (2026). Huntington’s disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion. Proceedings of the National Academy of Sciences, 123(10). https://doi.org/10.1073/pnas.2518854123

Vancouver

Lee E, Kim W, Beier DH, Lee Y, Kovalenko M, Saif F, et al. Huntington’s disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion. Proceedings of the National Academy of Sciences. 2026;123(10). doi:10.1073/pnas.2518854123

BibTeX
@article{Lee2026,
  author = {Lee, Eunhye and Kim, Wonju and Beier, David H and Lee, Yejin and Kovalenko, Marina and Saif, Faaiza and Oliver, Esaria and Srinageshwar, Bhairavi and Murtha, Ryan and Andrew, Marissa A and Jiang, Andrew and Gillis, Tammy and Demelo, Brigitte and Ruliera, Jayla and Lucente, Diane and Kwak, Seung and Lee, Ramee and Pinto, Ricardo Mouro and MacDonald, Marcy E and Gusella, James F and O'Brien, Patrick J and Wheeler, Vanessa C and Seong, Ihn Sik},
  title = {Huntington’s disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {10},
  doi = {10.1073/pnas.2518854123}
}
Kostenlos starten →